 My name is Andrew Ip. I'm a director of our Outcomes and Value Care Division and also a member of our Lymphoma Division. Lymphoma is a type of blood cancer. It's one of the most common types of blood cancer and it's very, very treatable, often curable. Well, when I treat a patient, I think the first thing that has to be focused on is the biology of the cancer, which is really the best way that we know how to treat lymphoma is if we have a target, we're going to go after it. And after the biology though, I really do try to look at the patient as a whole person. And I often take into account things like their social background, their spiritual background, and things that really encompass the whole patient when tailoring a patient's treatment. So really we're in the new age of immunotherapy in treating lymphoma at this time and what that means is we have a very exciting type of therapy platform called CAR T therapy, basically engineering a patient's own immune system cells and basically designing it so that it's a killer type of cell and that it's only going to kill the cancer cell and not other parts of the human body. And that's really the most exciting part of lymphoma treatment at this time. It's a huge type of research. What do I want to know when a patient comes to see me is, you know, I want them to know that I'm a doctor that's going to care for them and be there for them. And I think that's one of the most important things that may be missing in a lot of today's healthcare system is we're so focused on numbers and focused on just giving the right drugs to a patient, but they have families with them, they have friends with them, they have loved ones. And I really try to be a doctor that's going to treat them and their family and really treat them like they're my own family, really. I went into healthcare because I had family members with cancer and I take that still very personally to this day. And so when I see a patient, I see them as if they're my own family member because it's been very personal for me. And so I think I want patients to know that I'm right there with them.